CAMBRIDGE, Mass., Feb. 7, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc., (NASDAQ: IDIX) announced today that Idenix management will present a corporate overview at the 14th Annual BIO CEO & Investor Conference on February 14, 2012 at 10:00 a.m. ET at the Waldorf Astoria, New York City and at the Leerink Swann 2012 Global Healthcare Conference on February 15, 2012 at 3:00 p.m. ET at the Waldorf Astoria, New York City.
The live and archived webcasts of the company presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conferences.
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals Contacts: Kelly Barry (617) 995-9033 (media) Teri Dahlman (617) 995-9807 (investors)
SOURCE Idenix Pharmaceuticals, Inc.